Concordance study between ReproSeq and Veriseq system preimplantation genetic testing of aneuploidy

The vast majority of preimplantation genetic testing for aneuploidy (PGT-A) is performed using one of two NGS-based platforms, the VeriSeq-PGS platform from Illumina or the Ion ReproSeq-PGS platform from Thermo Fisher Scientific. However, there are few head-to-head data available comparing the two assays. Join us for this webinar, where Dr. Andrea will demonstrate how their team assessed the performance of these two platforms when selecting the assay that best suited the needs of their lab.

Learning Objectives:

• Learn how to investigate important PGT-A assay metrics, such as accuracy, precision, throughput and ease of use
• Gain working knowledge of how to test the limits of detection of a PGT-A assay, both with regards to resolution and mosaicism
• Discover how the two leading PGT-A platforms leverage sequencing data to interpret copy number variation

Register Now

Date: 11 December 2020

Join us for our upcoming webinar to learn about our Role of Next Gen Sequencing in SARS CoV2 Outbreak Management.

Speaker

Learn more about fast, accurate NGS for coronavirus research at thermofisher.com/ngs-coronavirus.

For Research Use, Only. Not for use in diagnostic procedures.